15 terminated. 15 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 15 | Terminated 15 |
Follow Colitis: new trials by email Literature Review of Colitis trials Research Report on Colitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An Open-label Study of Ozanimod in Moderate to Severe Ulcerative Colitis in Clinical Practice Ozanimod - Colitis, Ulcerative | Phase 4 | Terminated | Bristol-Myers Squibb | 139 | 2022-12-16 | 2026-02-10 |
| Prevention of Recurrent Clostridium Difficile Infection (CDI) in Patients With Inflammatory Bowel Disease (IBD). Bezlotoxumab - Inflammatory Bowel Diseases, Ulcerative Colitis | Phase 4 | Terminated | David Binion, MD | 19 | 2021-10-14 | 2025-06-05 |
| Efficacy and Safety of Teicoplanin in CDAD TEICOPLANIN - Clostridium Difficile Infection-associated Diarrhea and Colitis | Phase 4 | Terminated | Sanofi | 50 | 2020-05-15 | 2025-09-23 |
| Loss of Response of Adalimumab Biosimilar vs Adalimumab Original, in Inflammatory Bowel Disease. Amgevita 40Mg Solution for Injection, HUMIRA 40Mg Solution for Injection - Crohn Disease, Ulcerative Colitis | Phase 4 | Terminated | Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | 24 | 2019-10-10 | 2021-01-12 |
| TITRATE (inducTIon for acuTe ulceRATivE Colitis) Infliximab - Colitis, Ulcerative | Phase 4 | Terminated | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 50 | 2019-09-04 | 2025-02-06 |
| Endovenous Corticosteroid Pulses in Moderate Ulcerative Colitis Methylprednisolone, Prednisone - Ulcerative Colitis | Phase 4 | Terminated | Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa | 75 | 2018-10-11 | 2026-06-02 |
| A Study of Tofacitinib in Patients With Ulcerative Colitis in Stable Remission CP-690,500 5 mg, CP-690,550 10 mg - Ulcerative Colitis | Phase 4 | Terminated | Pfizer | 140 | 2017-11-16 | 2023-03-21 |
| Extended Access Program of Vedolizumab IV in Ulcerative Colitis and Crohn's Disease Vedolizumab - Colitis, Ulcerative, Crohn Disease | Phase 4 | Terminated | Takeda | 331 | 2016-08-01 | 2023-11-18 |
| Azathioprine Based on Endoscopy After Clinical Remission in Moderate to Severe Ulcerative Colitis Azathioprine, Placebo - Ulcerative Colitis | Phase 4 | Terminated | Kyungpook National University Hospital | 16 | 2016-02-01 | 2019-08-14 |
| Care Path for the Management of Ulcerative Colitis Enhanced treatment algorithm, Usual Care - Ulcerative Colitis | Phase 4 | Terminated | University of Western Ontario, Canada | 192 | 2014-05-01 | 2016-05-13 |
| Evaluation of Health Costs and Resource Utilization Measurement of drug (Adalimumab/Infliximab), Intensify treatment with the existing drug - Ulcerative Colitis, Crohn's Disease | Phase 4 | Terminated | University of Western Ontario, Canada | 51 | 2014-04-01 | 2016-05-13 |
| Efficacy of Gralise® for Chronic Pelvic Pain Gralise - Irritable Bowel Syndrome, Ulcerative Colitis | Phase 4 | Terminated | Shirley Ryan AbilityLab | 11 | 2012-08-01 | 2015-06-29 |
| A Study of Leukocytapheresis (LCAP) in Patients With Ulcerative Colitis (UC) Cellsorba EX - Ulcerative Colitis | Phase 4 | Terminated | Asahi Kasei Medical Co., Ltd. | 52 | 2009-05-01 | 2012-12-06 |
| Efficacy Study of Granulocytapheresis Plus Steroids vs Steroids Alone in Active Steroid Dependant Ulcerative Colitis Granulocyte Monocyte Apheresis (GMA-Apheresis) - Ulcerative Colitis | Phase 4 | Terminated | Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa | 133 | 2008-06-01 | 2015-09-07 |
| Study of Effects and of Modifications in Apoptosis Regulators Observed After Stopping 5-ASA Treatment in Patients With Inactive Ulcerative Colitis Observe patients with inactive ulcerative colitis - Ulcerative Colitis | Phase 4 | Terminated | Ferring Pharmaceuticals | 6 | 2005-06-01 | 2012-04-23 |
Colitis, Ulcerative (14) · Crohn Disease (4) · Inflammatory Bowel Diseases (4) · Clostridium Infections (1) · Cystitis, Interstitial (1) · Irritable Bowel Syndrome (1) · Pain (1) · Pelvic Pain (1) · Prostatitis (1)
Colonic Diseases (15) · Digestive System Diseases (15) · Gastroenteritis (15) · Gastrointestinal Diseases (15) · Intestinal Diseases (15) · Inflammatory Bowel Diseases (10) · Bacterial Infections (1) · Bacterial Infections and Mycoses (1) · Colonic Diseases, Functional (1) · Cystitis (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genital Diseases (1) · Genital Diseases, Male (1)
Adalimumab (2) · Infliximab (2) · Azathioprine (1) · CT-P13 (1) · Gabapentin (1) · Injections (1) · Methylprednisolone (1) · Prednisone (1) · Solutions (1) · Teicoplanin (1) · bezlotoxumab (1) · ozanimod (1) · tofacitinib (1) · vedolizumab (1)
Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (2) · University of Western Ontario, Canada (2) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1) · Asahi Kasei Medical Co., Ltd. (1) · Bristol-Myers Squibb (1) · David Binion, MD (1) · Ferring Pharmaceuticals (1) · Fundación Pública Andaluza para la gestión de la Investigación en Sevilla (1) · Kyungpook National University Hospital (1) · Pfizer (1) · Sanofi (1) · Shirley Ryan AbilityLab (1) · Takeda (1)
United States (5) · Spain (4) · Czechia (3) · Germany (3) · Italy (3) · South Korea (3) · France (2) · Hungary (2) · Japan (2) · Netherlands (2) · New Zealand (2) · Poland (2) · Russia (2) · Serbia (2) · South Africa (2)
Brian Feagan, MD (1) · Brian G Feagan, MD (1) · Daniel Ginard, MD (1) · David Binion, MD (1) · Eugeni Domenech, Ph D (1) · Eun Soo Kim, MD, PhD (1) · Fernando Magro, PhD (1) · Geert DHaens (1) · Julian Panes, Ph D (1)
PMID 33210333, PMID 35648151, PMID 36124702, PMID 38425446, PMID 38778549, PMID 40013523, PMID 40028509, PMID 41258993, PMID 41684725, PMID 42669025
2016 (1), 2017 (1)